EM
Elena Vance, AP
Claude Fable 5.1Associate Partner, Healthcare & MedTech
WebRTC Audio Stream (Latency: 210ms)
Input: Connected
Elena Vance (Interviewer)
22:15
"Welcome. Our client, AlphaHealth, is a \$4B US medical device manufacturer. Their flagship soft-tissue robotic surgical system has 72% US market share. The CEO is evaluating whether to enter the European Union market in the next 18 months. How would you structure this problem to advise her?"
You (Candidate)
23:04
"Thank you, Elena. To evaluate whether AlphaHealth should enter the EU robotic surgery market, I would like to structure my analysis around three core pillars: First, Financial & Market Attractiveness. Second, Operational & Regulatory Feasibility. And third, Competitive Dynamics & Go-to-Market Strategy."
Elena Vance (Interviewer)
24:10
"That sounds comprehensive. Let's look deeper into your first bucket. I have some initial data on the EU hospital adoption rates and regulatory CE mark timeline. Take a look at Exhibit 1."
Exhibits Vault
Click number to Pin to Scratchpad
Exhibit 1: EU Soft-Tissue Robotic Surgery Installed Base & TAM (2024-2029E)
Source: European Health Association, AlphaHealth Internal Strategy Estimates
Germany
420
€756M TAM
France
280
€504M TAM
United Kingdom
230
€414M TAM
Italy & Spain
190
€342M TAM
Rest of EU
180
€324M TAM
Total EU Installed Base:
1,300 units
(Total TAM: €2.34B)
Key Driver: Annual procedure volume growing at 22%
Interactive MECE Canvas & Scratchpad
Opus Evaluated: MECE Validated (94%)
Goal: EU Market Entry Decision & Strategy
Hypothesis: Enter via Germany & France first
1. Financial & Market Attractiveness
80/20 Priority
TAM & CAGR (16.4%)
€2.34B
Recurring Consumable GM
82%
2. Regulatory & Operational Feasibility
Key Risk
EU MDR & CE Mark
14 mo lead time
Surgeon Training Accreditation
Local centers
3. Competitor Response & GTM Model
Direct vs Distr.
Incumbent Lock-in
RoboSurge (64%)
Hospital Procurement Cycle
9-12 Months
Mental Math Scratchpad
Sanity Check: Passed
Germany TAM: €756M
Consumables: €2,200/kit
Opus Order-of-Magnitude check:
10^8 Range Validated
Opus 5.5 Shadow HUD
MBB Partner Assessment Engine
89.6 / 100
Strong Hire Trajectory
Live MBB Rubric Scores
92nd Percentile
1. MECE & Issue Structuring
94%
2. Quantitative Precision
88%
3. Hypothesis-Driven Inquiry
91%
4. Business Judgment & 80/20
85%
5. Executive Synthesis (Pyramid)
90%
Opus Shadow Coach Whispers
Live Feed
STRONG STRUCTURE
"Excellent opening hypothesis. You correctly isolated the financial size from the regulatory bottleneck."
80/20 DRIFT RISK
"In Exhibit 2, ensure you account for the 250 annual procedure rate when calculating consumable margins, not just upfront capital."
INTERVIEWER PROBING SOON
"Elena Vance is preparing to push back on European MDR CE Mark delays. Have a contingency go-to-market plan ready."